Betaliq
Betaliq is a biotech company that focuses on the development of ophthalmic beta-blockers.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Betaliq Information
Geographic Data
Address:
City: Tampa
State: Florida
Zip:
Country: United States
Financial Info
Stage:
seed
Raised Last:
$6M
Raised Total:$6M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Betaliq is a collaboration between Novaliq, GMBH, and BLP Management Group, LLC. It was formed to develop ophthalmic beta-blockers using Novaliq’s patented EyeSol non-water formulation technology. The company is developing two beta-blockers, for the treatment of glaucoma. BTQ 1901 is an EyeSol based formulation of a potent selective beta-blocker that has not previously been used to treat glaucoma. BTQ 1902 is an EyeSol based formulation of timolol, the most commonly prescribed beta-blockers.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2019 | Equity | $6M | 4/2019 | Seed Round | 1 | $6M |
Brookline Capital Markets Brookline Capital Markets |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
